|
SERP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23931984066894E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63358215843346E-12 |
| Normal-vs-Stage2 |
2.02360000001178E-06 |
| Normal-vs-Stage3 |
1.481350E-03 |
| Normal-vs-Stage4 |
5.808800E-04 |
| Stage1-vs-Stage2 |
4.051600E-01 |
| Stage1-vs-Stage3 |
7.016100E-02 |
| Stage1-vs-Stage4 |
2.057000E-01 |
| Stage2-vs-Stage3 |
3.808400E-01 |
| Stage2-vs-Stage4 |
6.391200E-01 |
| Stage3-vs-Stage4 |
7.787400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.26763052779688E-12 |
| Normal-vs-AfricanAmerican |
2.2215995709729E-10 |
| Normal-vs-Asian |
1.321570E-01 |
| Caucasian-vs-AfricanAmerican |
6.105400E-01 |
| Caucasian-vs-Asian |
5.290300E-02 |
| AfricanAmerican-vs-Asian |
7.123900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
2.34980000002327E-06 |
| Male-vs-Female |
4.966800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.44629996657164E-09 |
| Normal-vs-Extreme_Weight |
2.09721129351692E-12 |
| Normal-vs-Obese |
5.35940003487667E-09 |
| Normal-vs-Extreme_Obese |
2.3394999999482E-06 |
| Normal_Weight-vs-Extreme_Weight |
5.431000E-01 |
| Normal_Weight-vs-Obese |
7.734800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.454600E-01 |
| Extreme_Weight-vs-Obese |
3.092800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.660600E-01 |
| Obese-vs-Extreme_Obese |
5.287200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.995600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.3602010063305E-12 |
| Normal-vs-Age(61-80Yrs) |
7.54951656745106E-15 |
| Normal-vs-Age(81-100Yrs) |
1.09210000043269E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.684500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.225800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.325600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.973200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.698000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.265400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
3.91159993284873E-10 |
| Normal-VS-KIRP CIMP |
3.071800E-01 |
| Normal-VS-Unclassified PRCC |
6.05450001245345E-09 |
| Type1 PRCC-VS-Type2 PRCC |
4.795700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.018400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.007030E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.35169999982266E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
9.294000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.75200000002351E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.09540043702339E-10 |
| Normal-vs-N1 |
6.989800E-02 |
| Normal-vs-N2 |
6.598200E-03 |
| N0-vs-N1 |
1.496620E-03 |
| N0-vs-N2 |
7.009200E-01 |
| N1-vs-N2 |
3.396000E-01 |
|
|
